BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Israel
    • Rise of obesity
    • Radiopharmaceuticals
    • Biosimilars
    • Aging
    • IVDs on the rise
    • Coronavirus
    • Artificial intelligence

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Sunday, June 15, 2025
Home » Multimedia » Podcasts » BioWorld Insider Podcast

BioWorld Insider Podcast

One-on-one with medical innovators

Breakthrough medicines, billion-dollar deals, spectacular clinical successes and crushing failures all play a part in biopharma’s dynamic story. Developers make scientific advancements with the potential to change everything, only to face regulatory conundrums and ever-fluctuating markets. BioWorld tracks key events in the fast-moving sector every business day. Now, the BioWorld Insider podcast lets you hear directly from the movers and shakers whose collective work is changing how we all live. Join us each week for a new conversation.
Laurie-Halloran-president-and-CEO,-Halloran-Consulting-Group-podcast-9-2.png

Rising to the COVID-19 challenge, clinical trials evolve

Play
Listen
Duration: 25:00
09-02-2021

Laurie Halloran, president and CEO of Boston-based Halloran Consulting, shares her thoughts on the impact of COVID-19 on clinical trials.

Download transcript

Download episode
Mark Goldsmith, president and CEO, Revolution

A ‘Revolution’ in drugging the undruggable hits a speed bump but motors on

Play
Listen
Duration: 31:00
08-20-2021

Mark Goldsmith, Revolution Medicines Inc. president, CEO and chairman, talks about grappling with RAS mutations.

Download transcript

Download episode
Howard Fillit, executive director and chief science officer, Alzheimer’s Drug Discovery Foundation

As dementia cases grow, biomarkers and new therapies key to unlocking treatment

Play
Listen
Duration: 34:00
07-29-2021

Howard Fillit, founding executive director and chief science officer at the Alzheimer’s Drug Discovery Foundation, shares his insights on the impact of financial investments driving these therapies.

Download transcript

Download episode
Karen-Carey,-analyst,-BioWorld-podcast-7-8-.png

As biopharma deals keep pace, M&A volumes languish

Play
Listen
Duration: 14:00
07-08-2021

Biopharma deal-making activity, a closely watched marker of industry health, was alive and well in the second quarter. BioWorld Senior Analyst Karen Carey sifts through the numbers.

Download transcript

Download episode
Michel-Detheux,-CEO,-Iteos-podcast-6-16

Iteos brings Glaxosmithkline a third checkpoint-targeting antibody in a $2B deal

Play
Listen
Duration: 12:00
06-15-2021

Michel Detheux, president and CEO of Iteos Therapeutics Inc., discusses what his company brings GSK in a massive new deal.

Download transcript

Download episode
Ivana-Rubino,-Biogen,-podcast-6-10-.png

Finally, a new medicine for Alzheimer’s disease: One-on-one with Biogen’s Ivana Rubino

Play
Listen
Duration: 9:00
06-10-2021

Biogen’s vice president of global and U.S. medical affairs for Alzheimer’s disease offers insight into Aduhelm.

Download transcipt

Download episode
The BioWorld Insider Podcast logo

Introducing the BioWorld Insider Podcast

Play
Listen
Duration: 33
06-04-2021
Download episode
Previous 1 2 3 4 5 6 7 Next
More Multimedia
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing